Adimab, LLC
Activist
First SEC filing: Dec. 29, 2025 · Latest: Dec. 29, 2025
Biography
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 19, 2024 | IVVD | S | 5,000,000 | $3.95 | $19,750,000 | 21,687,906 Direct | -18.74% | Disposed | -79.2% (price as of 2026-10-02) |
| March 3, 2022 | IVVD | J | 1,158,089 | · | · | 26,687,906 Direct | -4.16% | Disposed | (price as of 2026-10-02) |
| Aug. 10, 2021 | IVVD | C | 128,064 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 10, 2021 | IVVD | C | 44,076 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 10, 2021 | IVVD | C | 5,000,000 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Aug. 10, 2021 | IVVD | C | 25,860,700 | · | · | 27,845,995 Direct | +1302.61% | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 10, 2021 | IVVD | Series C Preferred Stock | Common Stock | · | · | 128,064 | Disposed |
| Aug. 10, 2021 | IVVD | Series B Preferred Stock | Common Stock | · | · | 44,076 | Disposed |
| Aug. 10, 2021 | IVVD | Series A Preferred Stock | Common Stock | · | · | 5,000,000 | Disposed |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.